May 28, 2025 - 00:25

Chad Rigetti has announced the launch of his new startup, Sygaldry, which aims to revolutionize the intersection of quantum computing and artificial intelligence. Rigetti believes that Sygaldry will differentiate itself from existing competitors in the quantum space, as many of these companies developed their business strategies long before the recent surge in AI adoption.
In a discussion with Caroline Hyde and Ed Ludlow on a technology-focused platform, Rigetti emphasized the unique position of Sygaldry in a rapidly evolving market. He expressed confidence that the startup's fresh approach and innovative technology will allow it to capitalize on the growing demand for advanced AI solutions powered by quantum computing.
As industries increasingly seek to harness the power of AI, Rigetti's vision for Sygaldry positions the company to play a pivotal role in shaping the future of both quantum technology and artificial intelligence. The startup, backed by Y Combinator, is set to make waves in the tech world as it embarks on this ambitious journey.
August 9, 2026 - 18:31
County agenda features tax, technology and fairgroundsThe meeting will center on how to fund the ongoing fairgrounds project, a long-discussed priority for the county. Officials are expected to review the latest cost estimates and possible revenue...
August 9, 2026 - 00:24
‘AI slop’ crackdown: LinkedIn, Snap target low-quality gen-AI contentSocial platforms are starting to push back against the flood of generic, machine-generated posts, but they are doing so carefully. LinkedIn and Snap have both announced new measures aimed at...
August 8, 2026 - 05:47
Why GigaCloud Technology (GCT) Is Up 21.7% After Strong Q2 Results And New Buyback PlanGigaCloud Technology saw its stock surge 21.7% in early trading following the release of its second-quarter financial results and the announcement of a new capital return program. The company...
August 7, 2026 - 22:40
As FDA Approves First-Ever mRNA Flu Vaccine For Older Adults, Past KFF Polling Showed Most In This Age Group Were Uncertain About the Technology’s SafetyOn August 5, 2026, the U.S. Food and Drug Administration gave the green light to the first messenger RNA flu vaccine for adults aged 50 and older. The decision came after a clinical trial involving...